Mackenzie Financial Corp Axonics, Inc. Call Options Transaction History
Mackenzie Financial Corp
- $66.8 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding AXNX
# of Institutions
100Shares Held
21.6MCall Options Held
82KPut Options Held
65.3K-
Black Rock Inc. New York, NY4.34MShares$308 Million0.01% of portfolio
-
Westchester Capital Management, LLC Valhalla, NY1.45MShares$103 Million4.89% of portfolio
-
State Street Corp Boston, MA1.18MShares$84.1 Million0.0% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.05MShares$74.5 Million1.56% of portfolio
-
Aqr Arbitrage LLC Greenwich, CT854KShares$60.6 Million2.82% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.49B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...